Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
技術摘要-英文: Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
技術摘要-英文: Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
技術摘要-英文: Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
技術摘要-英文: Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
技術摘要-英文: Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
技術摘要-英文: Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
技術摘要-英文: Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.
技術摘要-英文: Disclosed are pyrazole compounds, encompassed by formula (I) shown in the specification, useful for treating peripheral cannabinoid 1 receptor mediated disorders. Also disclosed are pharmaceutical compositions and methods related to use of these compounds.